Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Senior Manager, Business Development & Licensing, China and APAC
Company: Bayer Healthcare
个人简介:
Lidia Li is currently the Senior Manager of Business Development and Licensing for China/APAC region at Bayer Healthcare Company. She has accumulated diverse professional experience in healthcare industry including strategy and portfolio management for both multinational companies and local players.  Before Joining Bayer, Lidia worked at IQVIA Management Consulting Group and Mundipharma as consultant and medical affair services professionals, during which she gained a lot of experience in healthcare industry knowledge, investment and due diligence. Lidia graduated from Peking Union Medical College, Tsinghua University in clinical medicine with a M.D. degree, and holds Medical Practitioner’s Qualification Certificate in China.
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Head of BD
Company: Alphamab Oncology
个人简介:
With over 10 years of  pharmaceutical industry experience in business development, strategy & alliance management, sales & marketing, had served various positions in many global leading pharma companies including Novartis, Johnson & Johnson, Boehringer Ingelheim and Eisai, led to complete a number of licensing deals, strategic cooperation and equity investment projects, owned a wealth of experience across all parts of business development value chain, familiar with immunology, neurology, respiratory and digestive fields. He has received a master's degree in biomedicine from the China Academy of Science and a bachelor's degree in biotechnology from Shandong University.
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Partner
Company: Pivotal bioVenture Partners China
个人简介:
Dianna joined Pivotal China in 2018 as a Partner. Dianna has 20+ years of healthcare expertise; previously as core healthcare investment member at Fidelity Asia Growth Partners and FountainVest Partners. Prior to that, Dianna worked as Vice President at Boehringer Ingelheim China in charge of Business Development and New Product Planning, and Engagement Manager at McKinsey’s China and US offices specializing in healthcare sector.Dianna graduated from Wharton Business School with an MBA degree in 2004.
发布时间: 2021 - 08 - 19
点击次数: 0
Positions: Partner
Company: Trinity Innovation (Beijing) Investment Management Co., Ltd
个人简介:
Trinity Innovation (Beijing) Investment Management Co., Ltd is an investment institution focusing on the field of biomedical innovation. Before starting the company, Dr. Yin Served as the managing director of SDIC Innovation Investment Management Co., Ltd., responsible for equity investment in the pharmaceutical and healthcare sector, such as Dizal, Ribo, Ascentage, CanSino, Bright-gene, Ribo and EpimAb. Dr. Yin Worked in both biotech and global multinational pharmaceutical companies Novartis,  responsible for innovative drug discovery and project management; Previous positions include Dean of the School of Pharmacy of Nankai University, Deputy Director of the State Key Laboratory of Medicinal Chemical Biology, and Executive Director of the Center for Basic Molecular Science of Tsinghua University. He has been employed as a member of several national industry and science and technology professional committees. Dr. Yin Zheng also served as the PWC Investment and M&A of Consulting Director, and carried out investment and M &A consulting business in the Biomedical Industry.Bachelor and Master degree from Nankai University; Ph.D. of Science, National University of Singapore.